Int J Health Plann Mgmt. 2020;35:773-787. wileyonlinelibrary.com/journal/hpm 773 change in their relationship and communication with patients, as clinicians accept to have their job reviewed and are not afraid to be evaluated by their patients. K E Y W O R D S patient reported experience measures, patient reported outcome measures, PREMs, PROMs, robotic surgery 1 | BACKGROUND After the approval of the da Vinci Surgical System in 2000 by the Food and Drug Administration (FDA), the past two decades have been characterised by the increased diffusion of such systems and the manufacturer's data show that as of 30 September 2017, there was an installed base of 4271 units worldwide, of which more than 60% in the USA, followed by Europe and Asia 1-3 . Although initially it was employed mainly for urologic procedures (namely radical prostatectomy), the evolution of both the surgical technique and the technology made possible the introduction of robotic surgical systems to a broader range of surgical specialties: cardiac, colorectal, general surgery, gynaecology, head and neck, and thoracic surgery.At the same time, there was a rise in the oncological conditions (OCs) that pose a great challenge to health care systems due to their increasing prevalence and expenditure. Indeed, cancer is the second leading cause of death worldwide behind cardiovascular diseases. In 2015, there were 17.5 M cancer cases worldwide, an increase by 33%with respect to 2005, and 8.7 M deaths 4,5 . However, the recent developments in personalised medicine, the continuous progress of cancer research, and the advance of mini-invasive surgical techniques have raised hope for patients and considerably improved cancer survival 6-9 . At the same time, the increasing cost of cancer treatments leads to an ongoing debate regarding both the equity and the affordability of care from individual and societal perspectives 10,11 .The continuously growing number of oncological procedures delivered by means of robotic surgical systems and the controversial debate regarding their cost-effectiveness with respect to traditional surgery led to the need of performance measurement systems to evaluate the effects of treatments, including surgery, that are able to go beyond the traditional clinical view of mortality and complications rates [12][13][14][15] . Beside the objective outcome measurements evaluated by clinicians, there are also subjective measures such as patient satisfaction, quality of life, and patient experience.PROMs have received increased attention as a useful tool to evaluate the effects of treatments and the outcomes of patients who underwent robotic oncological surgery, as the importance of the patient's perspective on disease impact has been increasingly recognised 16 . PROMs data have been initially introduced in clinical trials in order to integrate the clinical data with the people's subjective perception of their health status and health-related quality of life 17 . Most studies present the results of clinical trials and focus on radical prostatec...